Pharma funds - Tonic for ailing investors? - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Pharma funds - Tonic for ailing investors?

Apr 20, 2000

Nothing seems to be coming in the markets way on its south-bound journey. Even the NASDAQ, which recovered over the past two days did not mirror a rise in the local markets. With all stocks falling like nine-pins, investors could take a closer look at pharma stocks. There is no denying the fact that the sharp decline in the markets since the last week has been pervasive taking all sectors in its wake. But there is also no denying that software stocks have been hit the hardest. Nervousness on the NASDAQ has played its own role in pulling down software stocks. Earlier equitymaster.com had advised investors to wait patiently (as far as software funds are concerned) till the dust settles down (which could take a while).

Looking around, one realises that pharma stocks have not been hammered as badly as software. Whatever selling one has seen in pharma stocks has been largely due to redemption pressure on fund managers and due to the negative sentiment prevailing in the markets that has pulled down just about everything. The table below shows the performance of pharma funds over the past 5 days.

Pharma Funds NAV (Rs) as on  
  18-Apr-00 12-Apr-00 % Change
Kothari Pioneer Pharma Fund (Div) 10.3 10.9 -5.2
Kothari Pioneer Pharma Fund (Gr.) 10.3 10.9 -5.2
Magnum Pharma Fund 10.3 11.2 -8.0
UTI Pharma & Healthcare Fund 11.2 12.3 -9.4

While pharma funds have also fallen (like other sectoral funds) there is much merit in buying into pharma funds at current levels. Unlike software stocks, valuations of pharma stocks are more realistic. Pharma stocks are also immune from the strong undercurrents in the US markets, which gives Indian software stocks a cold every time the NASDAQ sneezes. In other words, pharma stocks are bound to reflect the performance of pharma companies more clearly as opposed to software stocks, which seem to be on their trip at present. And of course for the value investor, pharma funds are really cheap now.


Equitymaster requests your view! Post a comment on "Pharma funds - Tonic for ailing investors?". Click here!

  

More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

Can the Nifty Fall to 10,200? (Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

MARKET STATS